Emerson sees Q3 adjusted EPS $1.48-$1.52, consensus $1.54

Sees Q3 revenue up 4.5%-5.5%. Karsanbhai continued, “We have also marked the conclusion of Emerson’s (EMR) portfolio transformation with the completion of the AspenTech buy-in on March 12. We are pleased to be making significant progress on the integration. In addition, our review of strategic alternatives for our Safety & Productivity segment concluded the best value for our shareholders is to retain the business and continue to drive the segment’s industry leading margins and cash flow. Looking ahead, we are excited to capitalize on the growth potential of our transformed portfolio, supported by secular drivers, and to sustain the excellent operational performance we have consistently delivered since 2021.”